GRAVITY BLOG

Gravity Diagnostics Tests Over 100 COVID-19 Samples in First Four Days

By Gravity Diagnostics | March 20, 2020

  Gravity Diagnostics, a private clinical diagnostics laboratory located in Northern Kentucky, who has already been conducting a wide menu of testing for respiratory infections began testing for COVID-19 (Coronavirus) on Monday, March 16th, 2020. On February 28, 2020, the FDA released its emergency use guidance to allow high-complexity testing for CLIA certified laboratories in…

Northern Kentucky CLIA Laboratory Gravity Diagnostics Stepping Up to Test for COVID-19 (Coronavirus)

By Gravity Diagnostics | March 6, 2020

  As of March 5, 2020, the number of deaths in the United States attributed to COVID-19 is 14 with 200 confirmed cases in 19 different states. COVID-19 has been mandated as a serious public threat health by the Centers for Disease Control and Prevention (CDC). According to an article released by Reuters on March…

National Depression Education & Awareness Month

By Gravity Diagnostics | February 2, 2020

October is National Depression Education & Awareness Month! According to the National Institute of Mental Health (NIMH), 16.2 million adults in the U.S. suffer from major depressive disorder. As a result, suicide is the third major cause of death for those aged 15 to 24 and is continuing to rise. Depression is defined as: “A…

Do most of your patients use insurance when coming to your practice?

By Gravity Diagnostics | January 22, 2020

Do most of your patients use insurance when coming to your practice? If so, here are a few key policies to note as providers and office staff: Anthem Will NOT cover a drug confirmation without a drug screen WILL cover a drug screen and drug confirmation (in addition to non-detected prescribed medications, and medications that…

Have you ever heard of Pharmacogenomic (PGx) Testing?

By Gravity Diagnostics | January 3, 2020

Have you ever heard of Pharmacogenomic (PGx) Testing? A PGx test is used by a physician as a dosing guidance tool to help treat patients who are prescribed certain medications. Gravity Diagnostics offers PGx testing through a simple swab of the cheek—the following panels provide data for genes that code for over 130 medications: Mental…

The Importance of STI Tests

By Gravity Diagnostics | December 14, 2019

Have you ever been curious about the prevalence and importance of STIs? Gravity Diagnostics offers STI Testing through urine or e-genital swab for the following STIs: Herpes Simplex Virus 1 & 2 Chlamydia Trachomatis Gardnerella Vaginalis Ureaplasma Urealyticum Mycoplasma Genitalium: Trichomonas Vaginalis Neisseria Gonorrhoeae Chlamydia Trachomatis Gravity’s STI requisition form indicates the best patient population…

STI Testing

By Gravity Diagnostics | December 4, 2019

Did you know? Those who have Substance Use Disorders (SUDs) are at a higher risk for Sexually Transmitted Infections (STIs). Addiction recovery centers and substance abuse treatment centers present great opportunities to offer counseling for STIs. Those who have SUDs are at a higher risk for contracting an STI due to the behaviors associated with…

DL Isomer Testing Explained

By Gravity Diagnostics | November 26, 2019

Did you know? D/L Isomer testing is extremely important when it comes to medication management. Isomers are molecules that have the same molecular formula, but are arranged differently in space. For example, your hands can be seen as isomers. Your right and left hands both have the same type and amount of fingers, but your…

Gravity Diagnostics Announces Scientific Advisory Board

By Gravity Diagnostics | November 13, 2018

(Covington, KY) – Gravity Diagnostics is proud to introduce its Scientific Advisory Board. Each expert on the board brings a unique perspective to forward the company’s mission of reducing drug abuse and the addiction of controlled substances. Below are the members of our Scientific Advisory Board. Dr. Miriam Boeri received her doctorate of philosophy from…

Can Your DNA Predict Opioid Addiction?

By Gravity Diagnostics | August 29, 2018

New Research Partnership Between Bentley University and Gravity Diagnostics Will Explore the Genetic Link to Opioid Abuse. WALTHAM, Mass. and COVINGTON, Ky., June 11, 2018 /PRNewswire-USNewswire/ — Bentley University and Gravity Diagnostics have announced a partnership to conduct research that could inform doctors prescribing pain medication how likely a patient is to become addicted and…